Biochemistry, Genetics and Molecular Biology
Insulin Release
98%
Secretion (Process)
72%
Glucose Homeostasis
70%
Agonist
67%
Glucagon-Like Peptide-1
66%
Glucose Blood Level
55%
Glycation
55%
Gastric Inhibitory Polypeptide
51%
C-Peptide
51%
Biological Activity
48%
Blood Plasma
48%
Antidiabetic Activity
46%
Incretin
43%
Cell Function
39%
Glucose Transport
39%
Ob/Ob Mouse
39%
Dipeptidyl Peptidase
38%
Animal Model
37%
Insulin Resistance
36%
GPR120
34%
Glucose Metabolism
31%
Genomics
31%
Proinsulin
31%
Knockout Mouse
31%
High-Performance Liquid Chromatography
29%
Electrospray Mass Spectrometry
27%
Sorbitol
26%
Enteroendocrine Cell
25%
Glucose Oxidation
23%
Insulin Blood Level
22%
Immunocytochemistry
22%
Metabolomics
22%
Body Weight
21%
Glycemic Control
21%
Protein Glycation
21%
Streptozotocin
21%
Mouse Mutant
20%
Low Drug Dose
19%
GPR119
18%
GPR55
18%
Satiety
18%
Hyperglycemia
18%
G Protein Coupled Receptor
18%
Insulin Response
16%
Small Molecule
15%
GPR39
15%
Mass Spectrometry
15%
Sambucus nigra
15%
Cytochemistry
15%
Intravenous Immunoglobulin
15%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
G Protein Coupled Receptor
73%
Glucagon-Like Peptide-1
72%
Dipeptidyl Peptidase IV
69%
Diabetes Mellitus
65%
Receptor
50%
Glucagon Like Peptide 1 [7-36] Amide
49%
Gastric Inhibitory Polypeptide
47%
Nateglinide
47%
Fatty Acid
41%
Ob/Ob Mouse
41%
Sitagliptin
39%
Incretin
34%
Diabetic Obesity
33%
Biological Activity
33%
Cannabidiol
31%
Sorbitol
26%
Electrospray Ionization
26%
C Peptide
25%
Endocannabinoid
24%
Streptozotocin
23%
Glycosylated Protein
23%
Hyperglycemia
21%
Insulin Resistance
21%
Dipeptidyl Peptidase IV Inhibitor
20%
Radioimmunoassay
20%
Antidiabetic Agent
19%
Intraperitoneal Injection
19%
Cytotoxicity
18%
Metformin
18%
Glucose Intolerance
17%
Cannabinoid
15%
Mifepristone
15%
Sambucus nigra
15%
Knockout Mouse
15%
Calcium Ion
15%
Carbon 14
15%
11beta Hydroxysteroid Dehydrogenase 1
15%
Carbenoxolone
15%
Reverse Phase High Performance Liquid Chromatography
15%
Diet Induced Obesity
15%
Diseases
15%
Placebo
12%
Biological Marker
12%
Hydrocortisone
11%
Combination Therapy
11%
Endogenous Agonist
11%
Lactate Dehydrogenase
10%
Hyperbarism
10%
Alanine
10%
Medicine and Dentistry
Glucose Tolerance
76%
Antidiabetic Activity
49%
Secretion (Process)
42%
Diabetes
37%
Insulin Release
37%
Maturity Onset Diabetes of the Young
37%
Sitagliptin
31%
Beta Cell
28%
Pancreatic Islet
26%
Receptor
25%
Incretin
23%
Gastric Inhibitory Polypeptide
23%
Cell Function
22%
Insulin Sensitivity
21%
Intraperitoneal Drug Administration
21%
Glycation
20%
Glucagon Like Peptide 1
19%
Glucose Homeostasis
18%
Diabetic Obesity
15%
Human Insulin
15%
Biological Marker
15%
Fatty Acid
15%
Glucotoxicity
15%
Cannabidiol
15%
Enteroendocrine Cell
15%
Dipeptidyl Peptidase-4 Inhibitor
15%
Glucose Metabolism
15%
G Protein Coupled Receptor
15%
Insulin Tolerance Test
15%
Recombinant Human Insulin
15%
Immunohistochemistry
15%
11beta Hydroxysteroid Dehydrogenase 1
15%
Carbenoxolone
15%
Chronic Drug Administration
15%
Diet Induced Obesity
15%
Oral Drug Administration
13%
Body Weight
11%
Gene Expression
11%
Cytotoxicity
10%
Biological Activity
10%
Oxytocin
9%
Ob/Ob Mouse
9%
Doctor of Philosophy
7%
Biomedical Discipline
7%
Nutritional Biochemistry
7%
Upregulation
7%
Hormone Release
7%
Glucose Uptake
7%
Mass Spectrum
7%
Satiety
7%
